Biochemical Reagent
-
BA2037 AmitivirSummary: Amitivir (LY217896) is a thiadiazole derivative with broad antiviral activity against orthomyxoviruses and paramyxoviruses. - BA2038 CletoquineSummary: Cletoquine (Desethylhydroxychloroquine) is the main active metabolite of Hydroxychloroquine.
- BA2039 MitoxantroneSummary: Mitoxantrone is a potent topoisomerase II inhibitor.
- BA2041 MethisazoneSummary: Methisazone (Marboran) is an antiviral agent that works by inhibiting mRNA and protein synthesis.
-
BA2043 HydroxychloroquineSummary: Hydroxychloroquine (HCQ) is a synthetic oral antimalarial drug that is used in studies of malaria and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. - BA2044 TPE-MISummary: TPE-MI (Tetraphenylethenemaleimide) is intrinsically non-fluorescent before binding to thiols via maleimide.
- BA2045 HalofuginoneSummary: Halofuginone (RU-19110), a derivative of Febrifugine, is a competitive inhibitor of prolyl-tRNA synthetase.
- BA2046 RRx-001Summary: RRx-001 is a hypoxia-selective epigenetic factor used as a radiation or chemosensitizing agent that induces apoptosis and overcomes drug resistance in myeloma.
-
BA2047 EflornithineSummary: Eflornithine (DFMO) is a specific irreversible inhibitor of the enzyme ornithine decarboxylase. - BA2048 ObatoclaxSummary: Obatoclax (GX15-070), a BH3 mimetic, is a pan-family protein inhibitor.